New treatment strategy aims for Long-Term remission in blood cancer patients
NCT ID NCT06577025
Summary
This study is testing different sequences of newer immunotherapy drugs for people with newly diagnosed, standard-risk multiple myeloma. Researchers want to see if these treatment combinations can lead to long-term disease control with no detectable cancer cells remaining. The study will follow 43 participants for up to 5 years to measure how well the treatments work and how long the benefits last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Fundacao Antonio Prudente A C Camargo Cancer Center
São Paulo, 01509 900, Brazil
-
Hosp Clinico Univ de Salamanca
Salamanca, 37007, Spain
-
Hosp. Univ. 12 de Octubre
Madrid, 28041, Spain
-
Hosp. Univ. Marques de Valdecilla
Santander, 39008, Spain
-
Instituto D Or de Pesquisa e Ensino
Salvador, 41253 190, Brazil
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Peter MacCallum Cancer Centre
Melbourne, 3000, Australia
-
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, 05652 900, Brazil
-
The Alfred Hospital
Melbourne, 3004, Australia
-
Universitaetsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitaetsklinikum Tuebingen
Tübingen, 72076, Germany
-
Universitatsklinikum Wurzburg
Würzburg, 97080, Germany
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.